FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)Hans‐Joachim Schmoll, Alexander Stein, Christian Junghanß et al.|Annals of Oncology|2016Cited by 1